Total Payments
$9,515
2024 Payments
$693.84
Companies
29
Transactions
845
Medicare Patients
401
Medicare Billing
$144,083
Payment Breakdown by Category
Food & Beverage$9,339 (98.2%)
Education$175.90 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,339 | 842 | 98.2% |
| Education | $175.90 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,645 | 190 | $0 (2020) |
| ABBVIE INC. | $1,488 | 120 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,408 | 186 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $580.40 | 52 | $0 (2020) |
| Neos Therapeutics, LP | $501.94 | 38 | $0 (2020) |
| Supernus Pharmaceuticals, Inc. | $447.26 | 22 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $340.46 | 25 | $0 (2020) |
| Shire North American Group Inc | $338.64 | 32 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $332.76 | 23 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $288.82 | 15 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $693.84 | 35 | Supernus Pharmaceuticals, Inc. ($281.22) |
| 2023 | $645.96 | 38 | ABBVIE INC. ($424.76) |
| 2022 | $870.44 | 59 | Sunovion Pharmaceuticals Inc. ($348.96) |
| 2021 | $929.54 | 77 | AbbVie Inc. ($474.53) |
| 2020 | $806.87 | 77 | Allergan, Inc. ($459.15) |
| 2019 | $1,860 | 193 | Allergan Inc. ($373.71) |
| 2018 | $1,878 | 198 | Takeda Pharmaceuticals U.S.A., Inc. ($424.10) |
| 2017 | $1,829 | 168 | Allergan Inc. ($475.62) |
All Payment Transactions
845 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $3.07 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: SCHIZOPHRENIA | ||||||
| 04/03/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $34.55 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/29/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/28/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 02/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 49 | 273 | $119,886 | $24,931 |
| 2022 | 3 | 120 | 520 | $168,115 | $36,543 |
| 2021 | 2 | 118 | 472 | $124,637 | $32,155 |
| 2020 | 2 | 114 | 768 | $98,553 | $50,454 |
Total Patients
401
Total Services
2,033
Medicare Billing
$144,083
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 273 | $119,886 | $24,931 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 363 | $141,570 | $26,420 | 18.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 43 | 134 | $16,080 | $7,074 | 44.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 23 | $10,465 | $3,049 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 357 | $112,887 | $27,350 | 24.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 55 | 115 | $11,750 | $4,805 | 40.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 385 | $60,253 | $29,177 | 48.4% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 57 | 383 | $38,300 | $21,277 | 55.6% |
About Dr. Isabel Puri, MD
Dr. Isabel Puri, MD is a Psychiatry healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033154182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Isabel Puri, MD has received a total of $9,515 in payments from pharmaceutical and medical device companies, with $693.84 received in 2024. These payments were reported across 845 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($9,339).
As a Medicare-enrolled provider, Puri has provided services to 401 Medicare beneficiaries, totaling 2,033 services with total Medicare billing of $144,083. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Torrance, CA
- Active Since 06/20/2006
- Last Updated 10/08/2010
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1033154182
Products in Payments
- VRAYLAR (Drug) $3,079
- LATUDA (Drug) $1,408
- Trintellix (Drug) $722.87
- Adzenys XR-ODT (Drug) $325.90
- CAPLYTA (Drug) $305.90
- Evekeo (Drug) $296.67
- Qelbree (Drug) $281.22
- NUEDEXTA (Drug) $234.95
- SPRAVATO (Drug) $226.58
- VYVANSE (Drug) $223.63
- REXULTI (Drug) $214.15
- AUSTEDO (Drug) $189.82
- Cotempla XR-ODT (Drug) $176.04
- QELBREE (Drug) $166.04
- APLENZIN (Drug) $142.78
- MYDAYIS (Drug) $136.26
- TRINTELLIX (Drug) $117.49
- INVEGA SUSTENNA (Drug) $106.18
- Fanapt (Drug) $82.03
- BRINTELLIX (Drug) $81.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Torrance
Dr. James Pratty, M.d, M.D
Psychiatry — Payments: $780,597
Psychiatry $780,597
Dr. Lara Shirikjian, D.o, D.O
Psychiatry — Payments: $246,400
Psychiatry $246,400
Dr. Kartik Ananth, Md, MD
Psychiatry — Payments: $6,700
Psychiatry $6,700
Dr. David Ruderman, M.d, M.D
Psychiatry — Payments: $5,938
Psychiatry $5,938
Dr. Robert Winston, M.d, M.D
Psychiatry — Payments: $3,859
Psychiatry $3,859
Dr. Min Kim, Do, DO
Psychiatry — Payments: $3,374
Psychiatry $3,374